debt finance 15-11-2024Hercules Capital provides up to US$50m debt finance to AlectorAlector, Inc. a clinical-stage biotechnology company pioneering immuno-neurology, has announced the conclusion of a debt financing agreement with Hercules Capital, Inc. for up to US$50m. The agreement stipulates a US10m…Sign in or Upgrade to Continue ReadingThis news article is over 10 days old. Subscribe today to access all articles with an annual subscription. Become a member Learn moreAlready a subscriber? Log in here #Alector#debt finance#Hercules Capital